Kymera Therapeutics (KYMR) Financials

$114.96

$-2.04 (-1.74%)

As on 11-Sep-2026 16:00EDT

Market cap

$9,456 Mln

Revenue (TTM)

$105 Mln

P/E Ratio

--

P/B Ratio

6.4

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	104.99	39.20	47.07	78.59	46.83	72.83
Cost of Revenue	-0.06	--	7.37	189.08	2.98	2.40
Gross Profit	107.07	39.20	47.07	78.59	46.83	72.83
Operating Expenses	457.25	388.60	308.71	244.12	208.08	173.36
Operating Profit (EBIT)	-350.18	-349.40	-261.64	-165.53	-161.26	-100.53
Other Income	--	--	--	--	6.45	0.31
Profit before Tax	-299.87	-311.62	-223.86	-146.96	-154.81	-100.22
Provision for Tax	--	--	--	18.76	-2.98	-2.22
Profit after Tax (Net Income)	-299.65	-311.40	-223.86	-146.96	-154.81	-100.22
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-154.81	-100.22

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	1,509.26	1,579.66	835.62	394.97	490.15	459.64
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	64.86	79.94	74.65	95.10	41.64	53.73
Current Liabilities	74.99	83.21	67.77	85.69	71.34	92.54
Total Liabilities	1,724.10	1,742.81	978.04	575.76	603.13	605.91

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	902.00	871.60	467.77	170.44	183.72	154.63
Current Assets	737.27	871.21	510.27	405.32	419.42	451.27
Total Assets	1,716.77	1,742.81	978.04	575.76	603.13	605.91
Total Debt*	82.22	82.25	87.76	84.67	17.34	17.96
Net Current Assets	665.94	788.00	442.50	319.63	348.07	358.73

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-232.89	-194.50	-102.83	-153.09	-128.95
Cash Flow from Investing Activities	--	-521.06	-404.08	139.89	20.52	-99.84
Cash from Financing Activities	--	990.71	608.85	4.19	153.00	250.28
Net Cash Inflow / Outflow	--	--	--	--	20.43	21.50

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-3.31	-3.69	-2.80	-2.51	-2.67	-1.95
Cash EPS ($)	-3.25	-3.59	-2.71	-2.45	-2.62	-1.90
Adjusted Book Value ($)	18.23	18.72	10.45	6.75	8.47	8.94
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-2.76	-2.43	-1.76	-2.64	-2.51
Free Cash Flow per Share ($)	--	-2.78	-2.59	-2.35	-2.69	-2.54

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-24.09	-31.91	-29.78	-31.43	-25.71
ROE (%)	-19.40	-25.79	-36.38	-33.21	-32.60	-26.96
ROA (%)	-20.42	-22.89	-28.81	-24.93	-25.61	-18.34
EBIT Margin (%)	-227.20	-794.32	-475.04	-186.74	-330.23	-137.36
Net Margin (%)	-285.41	-794.39	-475.57	-186.99	-290.59	-137.01
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	134.82	-0.17	-0.40	0.68	-0.36	1.14
EBIT Growth (%)	13.30	-39.25	-52.36	5.09	-54.57	-119.98
Net Profit Growth (%)	-8.79	-39.11	-52.32	5.07	-54.47	-119.81
EPS Growth (%)	4.89	-0.32	-0.11	0.06	-0.37	-0.90
Book Value Growth (%)	27.30	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-21.09	-14.37	-10.14	-9.33	-32.56
Price / Book Value	6.45	4.16	3.85	3.77	2.95	7.10
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-9.49	-19.14	-13.03	-8.38	-6.96	-29.07
Close Price ($)	114.67	77.81	40.23	25.46	24.96	63.49
High Price ($)	130.05	103.00	53.27	39.85	66.45	87.85
Low Price ($)	36.65	19.45	22.36	9.60	13.15	29.93
Market Cap ($ Cr)	9,456.33	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.05	0.11	0.21	0.04	0.04
Short term debt to equity ratio	0.01	0.01	0.02	0.02	0.01	0.01
Current Ratio	9.83	10.47	7.53	4.73	5.88	4.88
Quick Ratio	9.91	--	--	4.73	6.05	4.97
Interest Coverage	-969.46	-1,250.50	-898.03	-748.81	-878.59	-571.67

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	19.05	--	2.01	23.87	5.42	0.19
Asset Turnover	0.07	0.03	0.06	0.13	0.08	0.13
Receivable days	--	8.82	76.46	49.49	10.42	3.93
Inventory Days	--	--	0.00	-11.83	-1,302.97	-13,133.23
Payable days	--	--	323.59	11.02	511.62	637.93
Cash Conversion Cycle	--	--	-247.12	26.64	-1,804.17	-13,767.23

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.